Dr. Jeffrey Berns discusses the implications of halting SYMPLICITY HTN-3, a study that was testing catheter-based renal denervation for the treatment of resistant hypertension.
Dr. Jeffrey Berns discusses the implications of halting SYMPLICITY HTN-3, a study that was testing catheter-based renal denervation for the treatment of resistant hypertension.